港股異動丨創科實業跌逾3% 美聯儲加息對美國樓市造成負面影響
格隆匯5月4日丨創科實業跌逾3%,報104.1港元,年內累積跌幅達33%,最新總市值1910億港元。週四美聯儲將公佈利率決議、美聯儲主席鮑威爾召開貨幣政策新聞發佈會。市場普遍預計美聯儲將加息50個基點。美國抵押貸款銀行家協會在4月27日公佈的數據顯示,截至4月22日當週,美國住房貸款平均利率升至2009年6月以來的最高水平,從一週前的5.20%上升至5.37%。與12個月前相比,它已經上漲220個基點,其中大部分上漲自2022年初以來。借貸成本的急劇上升將對美國樓市造成負面影響,而創科實業是全球領先的電動工具製造商,提供家居裝修、維修、保養、建造業及基建業產品,美國家得寶是公司渠道商兼最大客户。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.